- Home
- QMMM vs CGTX Comparison
QMMM vs CGTX Comparison
Compare QMMM & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMMM
- CGTX
- Stock Information
- Founded
- QMMM 2005
- CGTX 2007
- Country
- QMMM Hong Kong
- CGTX United States
- Employees
- QMMM N/A
- CGTX N/A
- Industry
- QMMM
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- QMMM
- CGTX Health Care
- Exchange
- QMMM NYSE
- CGTX Nasdaq
- Market Cap
- QMMM 19.6M
- CGTX 20.5M
- IPO Year
- QMMM 2024
- CGTX 2021
- Fundamental
- Price
- QMMM $1.26
- CGTX $0.30
- Analyst Decision
- QMMM
- CGTX Strong Buy
- Analyst Count
- QMMM 0
- CGTX 5
- Target Price
- QMMM N/A
- CGTX $5.63
- AVG Volume (30 Days)
- QMMM 3.0M
- CGTX 1.9M
- Earning Date
- QMMM 08-21-2025
- CGTX 08-07-2025
- Dividend Yield
- QMMM N/A
- CGTX N/A
- EPS Growth
- QMMM N/A
- CGTX N/A
- EPS
- QMMM N/A
- CGTX N/A
- Revenue
- QMMM $2,698,229.00
- CGTX N/A
- Revenue This Year
- QMMM N/A
- CGTX N/A
- Revenue Next Year
- QMMM N/A
- CGTX N/A
- P/E Ratio
- QMMM N/A
- CGTX N/A
- Revenue Growth
- QMMM N/A
- CGTX N/A
- 52 Week Low
- QMMM $0.54
- CGTX $0.22
- 52 Week High
- QMMM $13.00
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- QMMM N/A
- CGTX 48.87
- Support Level
- QMMM N/A
- CGTX $0.25
- Resistance Level
- QMMM N/A
- CGTX $0.33
- Average True Range (ATR)
- QMMM 0.00
- CGTX 0.03
- MACD
- QMMM 0.00
- CGTX 0.00
- Stochastic Oscillator
- QMMM 0.00
- CGTX 58.69
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.